The results of this analysis revealed aberrant expression patterns of ING1b and ING2 in six out of 31 lung cancer tissue samples, and in only one out of 30 lung cancer cell lines, i.e., in the NSCLC cell line NCI-H23. This evidence concerns the gene ING2 and non-small cell lung carcinoma.